Use of Pancreatic Enzymes in Short Bowel Syndrome
Completed · Phase 2
Conditions studied: Short Bowel Syndrome
In brief
Patients with short bowel syndrome have a high mortality rate that is mainly attributed to complications from central lines and long-term intravenous (IV) nutrition. There are few medical therapies to date that improve gut absorption in patients with short bowel syndrome. The primary objective of this study is to evaluate if absorption from the GI tract improves in subjects with short bowel syndrome following therapy with pancreatic enzymes.
Key facts
- Study ID
- NCT03097029
- Run by
- Children's Hospital of Philadelphia
- People needed
- 16
- Starts
- 2017-03-24
- Expected to finish
- 2019-02-01
- Last updated by the study team
- 2020-03-20
Who can join
Age: 4 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- history of a small bowel resection with subsequent dependence on parenteral nutrition for at least three months
- age 4 years to 65 years
- usual state of health for the past two weeks with no medication changes
- able to participate in a study for about four weeks with four study visits
- able to take pancreatic enzyme medication orally
You may not qualify if…
- significant disease other than short bowel syndrome affecting the gastrointestinal tract that impacts absorption or digestions
- motility disorder
- medications that directly alter fat absorption
- cholestatic liver disease defined as a serum conjugated bilirubin greater than 1.0 mg/dL, chronic renal failure, gout, or hyperuricemia
- history of a pork allergy
- women who are pregnant or lactating
- history of fibrosing colonopathy
- Those subjects who are eligible for the malabsorption blood test (MBT) test will be excluded if they have a history of a soy or safflower oil allergy.
Where it is running
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.